Sobi - Swedish Orphan Biovitrum AB

Sobi (Swedish Orphan Biovitrum) is a leading European Swedish biopharmaceutical company for rare disease treatment, headquartered in Stockholm. Specializes in haematology (haemophilia A and B) and immunology. With over 1,500 employees and global presence in 60+ countries.